Home/Pipeline/Gastric PD-L1

Gastric PD-L1

Gastric Cancer

CommercialActive

Key Facts

Indication
Gastric Cancer
Phase
Commercial
Status
Active
Company

About Mindpeak

Mindpeak is a Hamburg-based AI/ML company operating at the intersection of digital pathology and precision medicine. It has developed a suite of CE-marked, deep learning-based software products that automate the analysis of immunohistochemistry (IHC) and H&E-stained tissue samples, primarily for oncology biomarkers like PD-L1, HER2, and Ki-67. The company's value proposition centers on '0-click' integration, offering both standalone and deeply embedded solutions within partner laboratory information systems to improve pathologist efficiency and diagnostic consistency. Mindpeak appears to be in a commercial, revenue-generating stage, serving diagnostic labs, hospitals, and research institutions.

View full company profile

Therapeutic Areas

Other Gastric Cancer Drugs

DrugCompanyPhase
inPROBE for HER2SDS OpticPreclinical/Clinical Data Review
Venadaparib (IDX-1197)IdiencePhase 1b/2a
VNX-203Vironexis BiotherapeuticsPreclinical
Gastric Cancer BiomarkersParadise GenomicsDiscovery
TTFieldsNovocurePilot